The Risk of Long-acting Beta-Agonists Revisited - 19/08/11
Funding: There were no funding sources for this manuscript. |
|
Conflict of Interest: Drs. Aerik Williams and Shirley Fung have no conflict of interest. Dr. John R. Cohn has been a speaker for manufacturers of long-acting beta-agonist drugs, and a clinical investigator for GlaxoSmithKline. He has been a consultant in litigation involving long-acting beta-agonist drugs. |
|
Authorship: All authors participated in the preparation of this manuscript. |
Vol 124 - N° 3
P. e11 - mars 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?